Formulation and evaluation of nanostructured lipid carrier (NLC)-based gel of valdecoxib

Drug Development and Industrial Pharmacy

Volumn 32, Issue 8, 2006, Pages 911-918

  Joshi, M ^a   Patravale, V ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Anti inflammatory; Nanosturctured lipid carriers (NLC); Prolonged action; Topical; Valdecoxib

Indexed keywords

NANOPARTICLE; VALDECOXIB;

ANIMAL MODEL; ARTICLE; CENTRIFUGE; DISPERSION; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG SCREENING; ENCAPSULATION; FLOW KINETICS; GEL; IN VITRO STUDY; MICROEMULSION; NONHUMAN; PH; PHOTON CORRELATION SPECTROSCOPY; RAT; SKIN IRRITATION; SKIN TEST; SOLUBILITY;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; EDEMA; GELS; ISOXAZOLES; LIPIDS; MALE; NANOSTRUCTURES; RABBITS; RATS; RATS, WISTAR; SKIN IRRITANCY TESTS; SOLUBILITY; SULFONAMIDES;

EID: 33748498943     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600814676     Document Type: Article

References (17)

1. Bronaugh, R. L., & Maibach, H. L. (1982) In: Safety and Efficacy of Topical Drugs and Cosmetics. Kligman, A. M. and Leyden, J. J., Ed.; Grine and Stration Inc. New York., 51-59.
2. Gasco, M. R. (1993) Method of Producing solid lipid microspheres having narrow size distribution, US Patent No 5250236.
3. Gasco, M. R. (1997). Solid lipid nanospheres from warm microemulsions, Pharmaceutical Technology Europe, 9, 52-58.
4. Mehnert, W., & Mäder, K. (2001). Solid lipid nanoparticles-production, characterization and applications. Advanced Drug Delivery Reviews, 47, 165-196.
5. Müller, R. H., Mehnert, W., Lucks, J. S., Schwarz, C., zur Mühlen, A., Weyhers, H., Freitas, C., & Rühl, D. (1995). Solid lipid nanoparticles (SLN)-an alternative colloidal carrier system for controlled drug delivery. European Journal of Pharmaceutics and Biopharmaceutics, 41, 62-69.
6. Müller, R. H., Rühl, D., Runge, S., Schulze-Forster, K., & Mehnert, W. (1997). Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharmaceutical Research, 14, 458-462.
7. Müller, R. H., Mäder, K., & Gohla, S. (2000a). Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics, 50, 161-177.
8. Müller, R.H. (2000b), Solid-liquid (semi-solid) lipid particles and method of producing highly concentrated lipid particle dispersions. German Patent Application 199,45,203.2.
9. Müller, R. H., Mäder, K., Lippacher, A., & Jenning, V. (2000c). Festflüssige (halbfeste) Lipidpartikel und Verfahren zur Herstellung hochkonzentrierter Lipidpartikel-dispersionen. PCT/EP00/04565.
10. Müller, R. H., Radtke, M., & Wissing, S. A. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Advanced Drug Delivery Reviews, 54, 131-155.
11. Müller, R. H., Wissing, S. A., & Kayser, O. (2004). Solid lipid nanoparticles for parenteral drug delivery, Advanced Drug Delivery Reviews, 56, 1257-1272
12. Patravale, V. B., Date, A. A., & Kulkarni, R. M., (2004). Nanosuspensions: a promising drug delivery strategy. Journal of Pharmacy and Pharmacology, 56, 827-840.
13. Verneer, B. J. (1991). Skin irritation and sensitization. Journal of Controlled Release, 15, 261-265.
14. Vogel, G. H. (1997) In: Drug Discovery and Evaluation: Pharmacological Assays: Vogel, W. H. Ed.; Springer, New York, 407.
15. Wissing, S. A., & Müller, R. H. (2001). A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles. International Journal of Cosmetic Science, 23, 233-243.
16. Wissing, S. A., & Müller, R. H. (2002a). The influence of the crystallinity of lipid nanoparticles on their occlusive properties. International Journal of Pharmaceutics, 242, 377-379.
17. Wissing, S. A., & Müller, R. H. (2002b). Solid lipid Nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. Journal of Controlled Release, 81, 225-233.